AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ABBOTT LABORATORIES Director's Dealing 2017

Dec 5, 2017

29777_dirs_2017-12-05_83f545ab-52b5-46ee-9d87-2bcaf26882db.zip

Director's Dealing

Opens in your device viewer

{# SEO P0-1: filing HTML is rendered server-side so Googlebot sees the full text without executing JS or following an iframe to a Disallow'd CDN path. The content has already been sanitized through filings.seo.sanitize_filing_html. #}

SEC Form 4/A — Form 4/A

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2017-02-17

Reporting Person: WHITE MILES D (Director, Chairman and CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-02-17	Common shares without par value	A	92342	—	Acquired	3207105	Direct

Footnotes

F1: These shares represent performance vested restricted stock awards under the Abbott Laboratories 2009 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes.

F2: This Form 4/A amends the total amount of Abbott shares beneficially owned to include 4,836 shares held in the Judith S. White Living Trust. The reporting person was appointed trustee of the trust on January 16, 2017 and is the beneficiary of the shares in the trust.